IKT inhibikase.com Kompaniya foydasi

inhibikase.com (IKT) kompaniyasining rasmiy ramzlari

Inhibikase Therapeutics (IKT) asab tizimi patologiyalariga qarshi kurashish uchun tibbiy yechimlarni ishlab chiqishga ixtisoslashgan. Ushbu narxlar grafigi foyda dinamikasini aks ettiradi, u hozirda -0.06 darajasida turibdi. Brend neyrodegeneratsiyaning sabablarini butunlay yo'q qilish yo'llarini izlagani uchun e'tirofga sazovor bo'ldi. Hozirgi vaqtda Inhibikase Therapeutics (IKT) eng yirik farmatsevtika gigantlari bilan hamkorlikni yoqadigan darajaga yetish uchun klinik sinovlarni muvaffaqiyatli yakunlashga e'tibor qaratmoqda.

IKT (Inhibikase Therapeutics) Sof foyda tarixi 04.07.2022dan 01.11.2026gacha

Inhibikase Therapeutics, Inc. (IKT) moliyaviy va bozor koʻrsatkichlari kesimi

- joriy kotirovkalar va o'rtacha qiymat prognozi:
Birja grafigi Inhibikase Pharma|IKT - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Inhibikase Pharma|IKT - Korxona qiymati
- balans kapitallashuvi haqida ma'lumot:
Aksiyaning buxgalteriya qiymati Inhibikase Therapeutics|IKT - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi inhibikase.com|IKT - Kompaniyaning umumiy aktivlari
- qarz yuki va likvidlik ko'rsatkichlari:
Qarzning xususiy kapitalga nisbati Inhibikase Therapeutics|IKT - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli qarzning kapitalga koeffitsiyenti Inhibikase Therapeutics Inc|IKT - Kompaniya qarzlari|Balans kapitallashuviga qarzlar Inhibikase Pharma|IKT - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Inhibikase Therapeutics|Oraliq qoplama koeffitsiyenti inhibikase.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
IKT - Sof foyda
Kompaniyaning asosiy tahlili:Inhibikase Therapeutics
Inhibikase tayyor mahsulotlari

Ushbu ko'rsatkich emitentning investitsiya ishonchliligi uchun asosiy filtr vazifasini o'taydi. Metrika kapitalning bir birligi uchun sof foydani o'lchab, resurslardan foydalanishning haqiqiy samaradorligini aks ettiradi. Kompaniyaning foyda marjalarini tahlil qilish orqali investor biznesning fundamental holati dinamikasini real vaqt rejimida kuzatishi mumkin. Inhibikase Therapeutics (IKT) uchun ushbu grafik kapitalning kritik darajada kamayganini ko'rsatadi. Savdo mavjud bo'lmagan holda doimiy R&D xarajatlari joriy trayektoriya zararlilikka olib kelmoqda.

Toʻgʻridan-toʻgʻri raqobatchilar

BIIB - Sof moliyaviy natija|Kompaniyaning sof foydasi Neurocrine Biosciences|Kompaniya foydasi RGC (regencellbioscience.com)|Sof foyda AXSM|ACAD (ACADIA Pharma) - Yakuniy foyda|Sof foyda XENE (Xenon Pharmaceuticals Inc)|Sof moliyaviy natija Viking Therapeutics Corp (VKTX)|Supernus Pharmaceuticals - Sof foyda|CPRX: Kompaniyaning sof foydasi|DNLI: Sof foyda|HRMY - Sof moliyaviy natija|Kompaniyaning sof foydasi Biohaven Pharmaceutical|Sof foyda Amylyx Corp|Sof foyda TRVI|Sof foyda praxismedicines.com (PRAX)|Kompaniyaning sof foydasi Anavex Life Sciences Corp. AVXL|Sof moliyaviy natija CeriBell Inc (CBLL)|Prothena Biosciences - Sof foyda|Kompaniyaning sof daromadi Alector, Inc.|ANNX (Annexon, Inc.) - Sof daromad|Omeros - Yakuniy foyda|Sof daromad NGNE|ACIU (AC Immune S.A.) - Soliqlar to‘langandan keyingi foyda|Sof foyda VYGR|NMRA (Neumora Corp) - Yakuniy foyda|Sof foyda SCLX (Scilex Holding Company)|tevogen.com (TVGN) - Kompaniyaning sof daromadi|ACOG - Kompaniyaning sof foydasi|Yakuniy foyda CGTX (cogrx.com)|SAVA: Sof foyda|Assertio (ASRT) - Sof foyda|Kompaniyaning sof foydasi Coya Therapeutics Inc|VistaGen Therapeutics Inc - Soliqdan keyingi foyda|Sof foyda OVID|ABOS - Kompaniyaning sof daromadi|CervoMed Inc - Sof daromad|Sof foyda Alterity Therapeutics Ltd. ATHE|CLNN: Sof daromad|PepGen Inc. - Soliqlar to‘langandan keyingi foyda|JUNS: Sof foyda|RLMD - Sof moliyaviy natija|ANVS (Annovis Bio Corp) - Sof foyda|Sof daromad Grace Tx (GRCE)|Kompaniyaning sof foydasi Firefly Neuroscience, Inc (AIFF)|Sof moliyaviy natija anewmeds.com|Sof foyda NRSN (NeuroSense Therapeutics Ltd.)|Sof moliyaviy natija Reviva Pharmaceuticals Holdings Inc. (RVPH)|MTVA - Kompaniyaning sof foydasi|NRXS - Sof foyda|HSDT (heliusmedical.com) - Sof daromad|PASG: Soliqlar to‘langandan keyingi foyda|Kompaniyaning sof foydasi Neuphoria Therapeutics, Inc.|Kompaniya foydasi NERV (Minerva Neurosciences Inc)|Sof foyda ATHA|ADXN - Kompaniyaning sof daromadi|Alzamend Neuro - Sof daromad|Sof foyda Cyclerion Therapeutics Inc. CYCN|PTIX - Kompaniyaning sof foydasi|Yakuniy foyda KTTA (Pasithea Therapeutics)|cortigent.com (CRGT) - Kompaniyaning sof foydasi|Kompaniyaning sof daromadi Avenue Therapeutics Inc (ATXI)|BCLI (Brainstorm Cell) - Sof foyda|caratherapeutics.com (CARA) - Sof moliyaviy natija|Kompaniyaning sof foydasi Chromocell Therapeutics Corp. (CHRO)|eliemtx.com - Kompaniya foydasi|Sof foyda ITCI (Intra-Cellular Therapies, Inc.)|Yakuniy foyda LBPH|Marinus Pharmaceuticals - Sof foyda|Sof moliyaviy natija nkgenbiotech.com NKGN|NRBO: Sof foyda|SAGE (Sage Therapeutics Inc.) - Kompaniyaning sof foydasi|SNPX (Neurotrope) - Sof foyda|Trevena Inc (TRVN) - Sof moliyaviy natija|Kompaniyaning sof foydasi Vigil Neuroscience (VIGL)|Sof foyda Anew Medical Inc. (WENA)|Sof foyda CERE (Cerevel Therapeutics, Inc.)